Filing Details
- Accession Number:
- 0001415889-25-006955
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-05 16:28:19
- Reporting Period:
- 2025-03-04
- Filing Date:
- 2025-03-05
- Accepted Time:
- 2025-03-05 16:28:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650131 | Peter Radovich | C/O Mirum Pharmaceuticals, Inc. 989 E Hillsdale Blvd., Suite 300 Foster City CA 94404 | President And Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-04 | 13,681 | $45.57 | 13,280 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-03-04 | 1,169 | $45.74 | 12,111 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The weighted average sale price for the transaction reported was $45.571143, and the range of prices were between $45.50 and $45.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.